05 Apr Jonathan Adelson Named To Advisory Board Of Shanghai Based Private Equity And M&A Advisory Firm, Enoch Capital
Shanghai, China / New York, NY – April 5, 2016
Shanghai based private equity and cross-border advisory firm Enoch Capital announced today that Jonathan Adelson, Founder & CEO of New York based Adelson Strategies has agreed to act as an Advisory Board Member of the firm.
Mr. Adelson’s primary focus as a member of the Advisory Board will be to advise the firm in assisting its portfolio companies and advisory clients on foreign direct investment and entry into the US market, including the analysis of potential private equity investment and other joint venture opportunities.
Dr. Steven Li, Founder of Enoch Capital, said: “We are very pleased to have Jonathan on board as an Advisory Board member. He is experienced at building strong business relationships and identifying the drivers of growth that can provide the greatest opportunity for clients worldwide.”
Jonathan Adelson added: “I am delighted to be working with a firm that has such an outstanding reputation in China as Enoch Capital. I have known and worked along side with some members of their team for over 10 years, and their success across the range of their portfolio companies and eye towards fostering growth for their clients in both China and the U.S. makes this an exciting opportunity.”
Jonathan founded Adelson Strategies, a global international business development and strategy firm based in New York. Prior to that he was a Managing Director with Alvarez & Marsal Taxand, and worked with multinational corporations and their advisors around the world. Prior to that he was with the Washington and New York offices of a “Big 4” firm representing multinationals in dispute resolution with the Internal Revenue Service. He started his career at a Washington, DC-based government relations firm serving as an advocate for his clients before the U.S. Congress and the Executive Branch in the early 1990s.
Enoch Capital is a unique private equity investment firm which focuses its investment and advisory services in the specialty chemical, advance material and related industries. It was founded in 2010 by Dr. Steve Li, who has over 20 years of working experience in the chemical industry and middle market buy-out PE firms in US & Asia. He has substantial experience in domestic and multinational business operation and investment management.